Chris Rallis

Chris A.
Rallis currently works at Fennec Pharmaceuticals, Inc., as Independent Director from 2011, Aeolus Pharmaceuticals, Inc., as Independent Director from 2004, and Salisbury School, Inc., as Director.
Mr. Rallis also formerly worked at ImmunoBiosciences, Inc., as President & Chief Executive Officer from 2006 to 2007, ImmunoBiosciences, Inc., as President & Chief Executive Officer, Tenax Therapeutics, Inc., as Independent Director from 2011 to 2021, Triangle Pharmaceuticals, Inc., as President, Chief Operating Officer & Director from 1995 to 2003, Incara Pharmaceuticals Corp., as Director, Soligenix, Inc., as Director, EMD Millipore Corp., as Director, Lee's Pharmaceutical Holdings Ltd., as Director, Naicons Srl, as Director, and Burroughs Wellcome, as VP-Strategic Planning & Business Development.
Mr. Rallis received his graduate degree from Duke University and undergraduate degree from Harvard College.